US3271250A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapy and control of atherosclerotic diseases
Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1961-11-15
•
Granted: 1966-09-06
•
Expires: 1981-11-15
Abstract
No abstract record available.
Inventors
- 👤 Kanazawa Ken-Ichi
- 👤 Matsukawa Taizo
- 👤 Aramaki Yoshitomo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 23:31
CPC Classifications
C; C07; C07J; C07J9/00; C07J75/00
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
42 words
A METHOD OF CONTROLLING ATHEROSCLEROSIS IN A PATIENT SUBJECT TO HIGH BLOOD CHOLESTEROL LEVEL WHICH CONSISTS IN ADMINISTERING TO THE PATIENT AN EFFECTIVE AMOUNT OF A MEMBER SELECTED FROM THE GROUP CONSISTING OF CHOLESTANE-3,5,6TRIOL, CHOLESTANE-3,5,6-TRIOL 3,6-DIFORMATE, CHOLESTANE3,5,6-TRIOL 3-HEMISUCCINATE AND ALKALINE SALTS THEREOF.
Claim 2
Independent Claim
42 words
A METHOD OF CONTROLLING ATHEROSCLEROSIS IN A PATIENT SUBJECT TO HIGH BLOOD CHOLESTEROL LEVEL WHICH CONSISTS IN ADMINISTERING TO THE PATIENT AN EFFECTIVE AMOUNT OF A MEMBER SELECTED FROM THE GROUP CONSISTING OF CHOLESTANE-3,5,6TRIOL, CHOLESTANE-3,5,6-TRIOL 3,6-DIFORMATE, CHOLESTANE3,5,6-TRIOL 3-HEMISUCCINATE AND ALKALINE SALTS THEREOF.
References Cited (Backward Citations)
US2569300A
Cited
US2871160A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1969-09-05 | 1970-03-07 | 1970-09-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1973-09-05 | 1974-03-07 | 1974-09-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1977-09-05 | 1978-03-07 | 1978-09-06 | $7700.00 | Window Closed / Lapsed |